Dr. Andrew Axelrad, MD

Dr. Axelrad practices at Gastroenterology Associates of Northern Virginia, LLC in Reston, Virginia.

Dr. Axelrad's NPI, 1073579876, was assigned on April 21, 2006. Dr. Axelrad graduated from New York Medical College in 1989. Dr. Axelrad holds Virginia license 472345.

Dr. Axelrad's primary practice is Gastroenterology Associates of Northern Virginia, LLC, at 1939 Roland Clarke Pl, Reston, VA 20191 in Fairfax County. The practice phone is (703) 698-8960.

Dr. Axelrad's primary practice is Gastroenterology Associates of Northern Virginia, LLC in Reston, Virginia. Dr. Axelrad is also affiliated with Reston Hospital Center. The medical group on file is Gastro Health. Dmand AI also links Dr. Axelrad to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Axelrad practices, 2 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Axelrad's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Axelrad is board certified in gastroenterology by the American Board of Internal Medicine. Dmand AI has Dr. Axelrad's licenses on file in 3 states: Virginia, District of Columbia and Pennsylvania.

Dmand AI lists acid reflux, acute gallbladder or bile duct inflammation, chronic inflammatory bowel disease (IBD), cirrhosis of the liver, colonoscopy, gastroenteritis, gastrointestinal bleeding and hemorrhoids among the conditions Dr. Axelrad treats.

CMS data shows 13,445 Medicare services from Dr. Axelrad across 15 procedure codes in 2024, for 618 Medicare patients. Medicare paid $337,445 for them.

CMS counts 618 Medicare patients who saw Dr. Axelrad in 2024. The largest group is 65 to 74, with 303 patients. 75% of them have high cholesterol, and 64% have high blood pressure. 4% are also on Medicaid. Their average risk score is 1.03, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Axelrad's median patient age at 63, with 47% women.

In 2024, Dr. Axelrad wrote 378 Medicare Part D claims for 126 patients. 71% of them were for generic drugs. CMS names the drug for 246 of them, across 12 drugs with 11 or more claims each, at $685,020 in total drug cost. In 2023, CMS named 147 claims across 9 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 81 out of 100 for Dr. Axelrad for performance year 2024, reported as part of a group. Dr. Axelrad accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Axelrad as offering telehealth. CMS counts 154 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Axelrad, more than 86% of the clinicians it reports for that procedure.

Dmand AI links 5 papers to Dr. Axelrad. The most frequent topics are Stents, Deglutition Disorders and Equipment Design. Dr. Axelrad has published most often in Gastrointest Endosc. Dr. Axelrad's most frequent co-authors are Farid Gharagozloo, MD, Charles J. Lightdale, MD and Irving Waxman, MD.

CMS Open Payments shows 564 general payments to Dr. Axelrad from 38 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 99% of the total. Abbvie Inc. paid the most, $3,235.

Dr. Axelrad graduated from New York Medical College in 1989. Dr. Axelrad is a member of ACG.

Dr. Axelrad is in network with 17 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. Medicare plans come from the most carriers, 11. Check the plan with the practice before a visit.